Skip to content

A Study on Brain Functional Activity in the Treatment of Ankle Sprain Using the Yao-Ba-Zhu Technique Based on Functional Near-Infrared Spectroscopy Technology.

A Study on Brain Functional Activity in the Treatment of Ankle Sprain Using the Yao-Ba-Zhu Technique Based on Functional Near-Infrared Spectroscopy Technology.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002340
Enrollment
Unknown
Registered
2025-11-28
Start date
2024-11-26
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprain

Interventions

Shake-Pull-Poke Group:Shaking, pulling, and probing techniques intervention, followed by a washout period, and then self-shaking intervention.

Sponsors

Beijing University of Chinese Medicine Third Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: 2.1 Diagnostic Criteria: According to the Chinese Medicine Industry Standard "Criteria for the Diagnosis and Therapeutic Efficacy of Chinese Medicine Diseases" (1) A clear history of ankle trauma; (2) Immediate ankle pain, local swelling, subcutaneous ecchymosis, and limping after injury; (3) Significant local tenderness; in cases of inversion injury, severe pain occurs at the anterior-lateral aspect of the fibula when the foot is inverted; in cases of eversion injury, severe pain occurs at the anterior-medial aspect of the tibia when the foot is everted. 2.2 Inclusion Criteria (1) Meets the above diagnostic criteria; (2) Age between 18 and 78 years old; (3) Patients willing to accept and cooperate with treatment and follow-up, and able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 2.3 Exclusion Criteria (1) Abnormal sensory function in the ankle and foot region or presence of skin infections; (2) Patients with severe primary diseases of the cardiovascular, liver, kidney, or hematopoietic systems, or patients with mental illness; (3) Patients with an allergic constitution or known allergy to this type of drug or its components; (4) Patients with severe osteoporosis.

Design outcomes

Primary

MeasureTime frame
Blood Oxygen Saturation;

Secondary

MeasureTime frame
McGill Pain Questionnaire Score;Ankle and Hindfoot Functional Scoring;Proprioception;Ankle Joint Swelling Assessment;Functional Recovery Assessment;Adverse Event Recording;

Countries

China

Contacts

Public ContactZhaojun Chen

Beijing University of Chinese Medicine Third Affiliated Hospital

zhaojunchen66@126.com13701356673

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026